Biopharma | May 13, 2026
Agilent and Veeda collaborate to strengthen regulatory-ready biopharma analytics
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Paves way for CNS cancer test rollout
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
Subscribe To Our Newsletter & Stay Updated
